Balyasny Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-53,170
| Closed | -$319K | – | 1963 |
|
|
2024
Q4 | $319K | Buy |
+53,170
| New | +$319K | ﹤0.01% | 1612 |
|
|
2024
Q3 | – | Sell |
-29,227
| Closed | -$106K | – | 1912 |
|
|
2024
Q2 | $106K | Buy |
29,227
+9,341
| +47% | +$33.8K | ﹤0.01% | 1762 |
|
|
2024
Q1 | $63.8K | Buy |
+19,886
| New | +$63.8K | ﹤0.01% | 1895 |
|
|
2022
Q3 | – | Sell |
-618,658
| Closed | -$5.01M | – | 2322 |
|
|
2022
Q2 | $5.01M | Buy |
+618,658
| New | +$5.01M | 0.02% | 753 |
|
|
2022
Q1 | – | Sell |
-76,324
| Closed | -$2.14M | – | 2078 |
|
|
2021
Q4 | $2.14M | Sell |
76,324
-61,932
| -45% | -$1.74M | 0.01% | 994 |
|
|
2021
Q3 | $4.7M | Buy |
138,256
+99,222
| +254% | +$3.37M | 0.02% | 691 |
|
|
2021
Q2 | $1.6M | Buy |
+39,034
| New | +$1.6M | 0.01% | 961 |
|
|
2021
Q1 | – | Sell |
-50,521
| Closed | -$2.99M | – | 1524 |
|
|
2020
Q4 | $2.99M | Sell |
50,521
-132,113
| -72% | -$7.81M | 0.02% | 663 |
|
|
2020
Q3 | $8.88M | Buy |
182,634
+161,731
| +774% | +$7.86M | 0.07% | 360 |
|
|
2020
Q2 | $1.01M | Buy |
+20,903
| New | +$1.01M | 0.01% | 667 |
|
|
2020
Q1 | – | Sell |
-424,087
| Closed | -$12.7M | – | 987 |
|
|
2019
Q4 | $12.7M | Buy |
+424,087
| New | +$12.7M | 0.08% | 330 |
|